Guanfacine (Tenex) 0.5mg Duration in the Body
Guanfacine remains in your body for approximately 17 hours on average (half-life), meaning it takes about 3-4 days to reach steady-state levels and roughly 3-4 days to be mostly eliminated after stopping. 1
Pharmacokinetic Details
Elimination Half-Life
- Average: 17 hours (range 10-30 hours) in individuals with normal renal function 1
- Younger patients: shorter half-lives (13-14 hours)
- Older patients: half-lives at the upper end of the range (up to 30 hours)
Time to Peak Concentration
- Peak plasma levels occur 1-4 hours after oral dosing (average 2.6 hours) 1
Time to Steady State
- Steady-state blood levels are reached within 4 days in most patients 1
Bioavailability and Distribution
- Oral bioavailability: approximately 80% 1, 2
- Protein binding: approximately 70% 1
- High volume of distribution (mean 6.3 L/kg), indicating extensive tissue distribution 1
Elimination Pathways
Renal Excretion
- 50% (range 40-75%) eliminated unchanged in urine 1
- Renal clearance represents about 50% of total body clearance 2
Hepatic Metabolism
- Remaining drug metabolized primarily via CYP3A4 3
- Metabolites excreted as conjugates from oxidative metabolism 1
Clinical Implications
Duration of Effect
- The 24-hour duration of action makes once-daily dosing feasible 1
- Blood pressure effects maintained for full 24 hours, though some numerical decrease at 24 hours suggests possible escape in some patients 1
Withdrawal Considerations
After stopping guanfacine:
- Blood pressure typically returns to pretreatment levels slowly over 2-4 days 1
- This delayed return is consistent with the longer half-life compared to clonidine 1
- Rebound hypertension frequency is low but can occur 2-4 days after discontinuation 1
Special Populations
Renal impairment: The elimination half-life remains approximately 14 hours even in patients with severe renal dysfunction (GFR <10 mL/min), as non-renal elimination compensates 4. However, use lower doses in renal impairment 1.
Dialysis: Guanfacine is poorly dialyzed (only 2.4% removed during 5-hour hemodialysis), so usual doses can be given regardless of dialysis timing 5.
Important Caveats
The 0.5mg dose you mentioned is below the typical therapeutic range for most indications. Standard dosing typically starts at 1mg daily 1, and the 0.5mg dose showed similar efficacy to placebo in clinical trials 1. At this low dose, the pharmacokinetic parameters remain the same, but clinical effects may be minimal.